5 Notable Bain Capital Investments

Bain Capital's Strategic Moves and Investments 1. **Expansion into Israel**: Bain Capital Ventures (BCV) has opened an office in Israel and appointed 26-year-old Ain Ron Maadenick as a partner and manager of Israel Operations. This expansion is part of BCV's strategy to invest in Israeli technology companies, as evidenced by their significant investments in companies like Crosby and PRONTO. 2. **Investment in Biotech**: Bain Capital has demonstrated its interest in the biopharma sector by investing in a $300 million partnership with Bristol Myers Squibb. This partnership involves building a standalone "champion" immunology company with FDA-approved drugs, showcasing Bain's focus on innovative healthcare solutions. 3. **Potential Take-Private Offer for Canada Goose**: Bain Capital, Canada Goose's main shareholder, has received bids to take the company private, with the company's valuation soaring to approximately $137 billion. This move follows Bain's initial investment in Canada Goose in 2013 and aligns with their strategy to capitalize on opportunities in the luxury goods market. In conclusion, Bain Capital is actively expanding its operations and investments across various sectors, including technology and biopharma, while also considering strategic exits through take-private offers. These moves reflect the firm's dynamic and forward-looking approach to capitalizing on growth opportunities.